Siemens Healthineers AG

Annual Shareholders' Meeting 

The Annual Shareholders‘ Meeting 2024 of Siemens Healthineers AG will be held on Thursday, April 18, 2024, at 10:00 a.m. (CEST), as a virtual Annual Shareholders’ Meeting without the physical presence of the shareholders or their authorized representatives (with the exception of the proxy representatives designated by the Company).

6min

Are you a shareholder?

Access the shareholder portal by entering your shareholder number and the password selected by you or by entering the access information provided to you in the registration material. The shareholder portal will be available for registration (inter alia) as of Wednesday, March 6, 2024.

Shareholder service
For further questions on the Annual Shareholders’ Meeting, please contact the shareholder service from Mondays to Fridays – except on public holidays – between 09:00 a.m. and 05:00 p.m. (CET; as of March 31, 2024, CEST). 
+49 89 30903-6346
aktionaersportal@computershare.de

Annual Shareholders' Meeting 2024

On the day of the Annual Shareholders’ Meeting from 10:00 a.m. (CEST), the speeches of the Chairperson of the Supervisory Board, Prof. Dr. Ralf P. Thomas, and the Chief Executive Officer, Dr. Bernd Montag, can be followed live here. After the Annual Shareholders’ Meeting, a recording of these speeches will be available here.

Annual Shareholders Meeting 2024

Key dates

Publication of Notice of Annual Shareholders’ Meeting in the German Federal Gazette (Bundesanzeiger) and on the website

Wednesday, February 7, 2024

Begin of distribution of Notice of Annual Shareholders’ Meeting

starting Wednesday, March 6, 2024

Availability of shareholder portal for registration (inter alia)

starting Wednesday, March 6, 2024

Deadline for registration (technical record date)

Thursday, April 11, 2024, midnight (CEST)

Due date of the dividend

Tuesday, April 23, 2024

Notice & documents

Key items of the speeches of the Chairperson of the Supervisory Board, Prof. Dr. Ralf P. Thomas, and of the Chief Executive Officer, Dr. Bernd Montag, are available here (Advance Publication as of April 10, 2024).

Data privacy notice

Learn more about our innovations in Patient Twinning, Precision Therapy as well as Digital, Data and AI:

Archive